FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

 

FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

Bank Accounts Opened with National ID

Some 4.5 million Filipinos were able to open a bank account…
FDA Authorizes Novavax COVID Vaccine

EU Needs Geopolitical Muscle

EU foreign policy chief Josep Borrell says that the fall of…
FDA Authorizes Novavax COVID Vaccine

Bank of America, Lowe’s Sponsored CRT Training

Bank of America, Lowe's, and Truist Financial Corporation sponsored…